Core Center for Stem Cell and Transplantation Biology

干细胞和移植生物学核心中心

• 批准号: 8971761
• 负责人: BEVERLY J. TOROK-STORB
• 金额: $ 100万
• 依托单位: FRED HUTCHINSON CANCER RESEARCH CENTER
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-08-01 至 2020-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8971761
• 关键词: Address; Adult; Animal Model; Animals; Archives; Area; Back; Base Sequence; Biological Assay; Biology; Biomedical Research; Blood; Canis familiaris; Cell Line; Cells; Charge; Clinical; Clustered Regularly Interspaced Short Palindromic Repeats; Collaborations; Consultations; Country; Custom; Data; Development; Direct Costs; Disease; Equipment; Gene Expression; Generations; Goals; Harvest; Hematological Disease; Hematology; Hematopoiesis; Hematopoietic; Hematopoietic Stem Cell Transplantation; Human; IACUC; In Vitro; Income; Individual; Institution; Libraries; Life; Link; Marrow; Minisatellite Repeats; Modeling; Molecular; Molecular Bank; Mus; National Institute of Diabetes and Digestive and Kidney Diseases; Non-Malignant; Outcome; Patients; Positioning Attribute; Pre-Clinical Model; Preclinical Testing; Process; Production; Protocols documentation; Reagent; Recruitment Activity; Reporter; Research; Research Design; Research Personnel; Resource Sharing; Resources; Reverse Transcriptase Polymerase Chain Reaction; Services; Speed; Stem cell transplant; Stem cells; Structure; System; Techniques; Technology; Training; Transduction Gene; Transgenic Model; Translations; Transplantation; Umbilical Cord Blood; Work; adeno-associated viral vector; base; cost; cytokine; data sharing; design; experience; genome editing; graft vs host disease; improved; in vivo; induced pluripotent stem cell; meetings; member; mouse model; operation; preclinical study; programs; protocol development; public health relevance; ranpirnase; response; screening; small hairpin RNA; stem; stromal progenitor population; vector

 DESCRIPTION (provided by applicant): This application proposes a transition from a P30 Core Center of Excellence in Hematology (DK056465-16) to an NIDDK-sponsored U54 Cooperative Hematology Specialized Core Center (CHSCC). This transition will facilitate collaborations, training, and resource sharing on a national level. The goal of this CHSCC is to advance research in stem cell and transplantation biology and thereby accelerate the development of new therapies. This requires resources that anticipate and meet the needs of an ever evolving research base. Our past experience has shown that new investigators can be recruited into this area of research if critical cells, technologies, and expertise can be accessed at reasonable cost. To address these needs we are proposing to provide an Administrative Core and five biomedical research cores. These include Cell Procurement and Processing, to provide large quantities of purified normal hematopoietic stem, progenitor, and stromal populations harvested from adult blood and marrow as well as cord blood and induced pluripotent stem cells (iPSC); Vector Production to provide lenti, retro, foamy and adeno-associated virus vectors for gene transduction, marking, and editing; Specialized Mouse Services including in vivo xenogeneic transplantation assays and the generation of custom transgenic models; the Canine Large Animal Model for preclinical studies including protocol development and IACUC approval; and Molecular Library Development and Screening, that provides access to CRISPR genome editing and shRNA libraries. The services provided by these cores will enable individual investigators to: 1) isolate and characterize stem/progenitor cells, 2) genetically mark, edit or otherwise alter their gene expression, 3) accurately detect and quantitate their progeny in vitro and in vivo, and 4) determine the effects of these manipulations on hematopoiesis at the molecular, cellular, and whole animal levels. The Administrative Core provides budgetary and scientific oversight of all CHSCC activities, and manages a charge back system to generate program income. Program income is used to enhance and expand Core operations as well as support the Pilot & Feasibility (P&F) and Enrichment programs designed for trainees and young investigators in the CHSCC network. Finally, the Administrative Core will work with Sage Bionetworks to create a publicly searchable data archive linking investigators to annotated data, techniques, and protocols generated through the CHSCC programs. The 30 member research base of this CHSCC receives more than 29 million/year direct costs in non-malignant Hematology-related research, 3.8 million comes directly from the NIDDK.

 描述（由申请人提供）：本申请建议从P30血液学卓越核心中心（DK 056465 -16）过渡到NIDDK赞助的U 54血液学专业核心中心（CHSCC）。这一过渡将促进国家一级的合作、培训和资源共享。该CHSCC的目标是推进干细胞和移植生物学的研究，从而加速新疗法的开发。这就需要资源，预测和满足不断发展的研究基地的需要。我们过去的经验表明，如果能够获得关键的细胞、技术和专业知识， 以合理的价格。为了满足这些需求，我们建议提供一个行政核心和五个生物医学研究核心。这些包括细胞获取和处理，以提供从成人血液和骨髓以及脐带血和诱导多能干细胞（iPSC）收获的大量纯化的正常造血干细胞、祖细胞和基质群体;载体生产，以提供慢病毒、逆转录病毒、泡沫病毒和腺相关病毒载体用于基因转导、标记和编辑;专门的小鼠服务，包括体内异种移植试验和定制转基因模型的生成;用于临床前研究的犬大型动物模型，包括方案开发和IACUC批准;和分子文库开发和筛选，提供CRISPR基因组编辑和shRNA文库的访问。这些核心提供的服务将使个体研究者能够：1）分离和表征干/祖细胞，2）遗传标记，编辑或以其他方式改变其基因表达，3）准确检测和定量其体外和体内后代，以及4）确定这些操作对分子，细胞和整个动物水平造血的影响。行政核心为所有CHSCC活动提供预算和科学监督，并管理收费系统以产生计划收入。计划收入用于加强和扩大核心业务，并支持为CHSCC网络中的学员和年轻研究人员设计的试点和可行性（P&F）和充实计划。最后，行政核心将与Sage Bionetworks合作，创建一个可公开搜索的数据档案，将调查人员与通过CHSCC项目生成的注释数据、技术和协议联系起来。该CHSCC的30名成员研究基地每年在非恶性血液学相关研究中获得超过2900万美元的直接费用，其中380万美元直接来自NIDDK。